Alliance aims to expand access to innovative healthcare solutions.
Eversana, a global services provider for the life science industry, is establishing a strategic partnership with the China Resources Pharmaceutical Commercial Group, a pharmaceutical distribution enterprise. As part of the union, the two organizations are expected to collaborate on expanding healthcare solutions both nationally and outside of China to ultimately discover new treatment options for a variety of diseases.
"We know that to make the biggest impact in the region and across the globe, we must find ways to break down existing barriers and bring innovative therapies both in and outside of China,” said Jim Lang, CEO, Eversana. “Through this alliance, we’ll work to establish a framework that can drive innovation, enhance patient care, and create transformative advancements for patients throughout the globe."
Reference: EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally. June 1, 2023/PR Newsire
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.